Peptide promotes overcoming of the division limit in human somatic cell.
Level 5 - mechanism / opinion, no new human data
In vitro bench research on cultured human cells
PubMed 15455129 · doi:10.1023/b:bebm.0000038164.49947.8c
What was done
Primary pulmonary fibroblasts isolated from a 24-week human fetus were grown in culture until reaching replicative senescence at passage 34. Researchers evaluated the effect of adding the tetrapeptide Epithalon (Ala-Glu-Asp-Gly) to these aging cells on telomere length and cellular lifespan compared to untreated controls.
What was found
Control fibroblasts ceased dividing at passage 34 with shortened telomeres compared to early passage 10 cells. Treatment with Epithalon elongated telomeres back to lengths comparable to passage 10 and allowed the cells to undergo 10 additional divisions (reaching 44 passages) with ongoing replication. Specific numerical measurements of telomere lengths, variance, and statistical significance values were not reported in the abstract.
Why it matters
Provides in vitro proof-of-concept that small peptide administration can extend the Hayflick limit and restore telomere length in cultured human somatic cells.
Limits
This was strictly an in vitro experiment conducted on a single cell strain derived from one 24-week fetus. The abstract omits precise quantification of telomere base pairs, replicate numbers, statistical tests, and long-term genomic stability or oncogenic transformation assays. Findings from fetal cell culture cannot be extrapolated directly to adult human physiology or clinical outcomes.
Cited by
- supports Epithalon works by enhancing telomerase activity to lengthen or protect cellular telomeres.